Point of Care Infectious Disease Testing Market Size, Share, Trends, Growth Outlook

Point of Care Infectious Disease Testing Market is estimated to increase at a growth rate of 11.3% CAGR over the forecast period from 2024 to 2030.

The global Point of Care Infectious Disease Testing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others).

An introduction to Point of Care Infectious Disease Testing Market in 2024

The point of care infectious disease testing market is witnessing significant growth in 2024, driven by the global burden of infectious diseases, the demand for rapid diagnostic solutions, and the advancements in point-of-care testing technologies such as molecular diagnostics, immunoassays, and biosensors. Point of care infectious disease tests enable rapid detection and identification of pathogens, antimicrobial resistance, and infectious disease biomarkers at the patient's bedside or in community settings, facilitating timely treatment decisions and infection control measures. With innovations in assay development, instrument miniaturization, and connectivity features, the market is experiencing rapid expansion and adoption of point of care infectious disease testing solutions, empowering healthcare providers to combat infectious diseases more effectively and reduce the spread of infections.

Point of Care Infectious Disease Testing Market Trend: Expansion of Point-of-Care Testing (POCT) for Infectious Diseases

A prominent trend in the Point of Care Infectious Disease Testing Market is the expansion of point-of-care testing (POCT) for infectious diseases. With the increasing prevalence of infectious diseases and the need for rapid diagnosis, there is a growing demand for decentralized testing solutions that can deliver quick and accurate results outside of traditional laboratory settings. POCT devices for infectious diseases offer the advantage of rapid turnaround time, enabling timely diagnosis, treatment initiation, and infection control measures.

Point of Care Infectious Disease Testing Market Driver: Urgency for Early Detection and Management of Infectious Diseases

The primary driver of the Point of Care Infectious Disease Testing Market is the urgency for early detection and management of infectious diseases. Timely diagnosis is crucial for effective disease management, especially in the case of infectious diseases where prompt identification can prevent further transmission and improve patient outcomes. Point-of-care testing facilitates rapid diagnosis at the patient's bedside, in clinics, or community settings, enabling healthcare providers to initiate appropriate treatment and implement infection control measures promptly.

Point of Care Infectious Disease Testing Market Opportunity: Integration with Digital Health Platforms

An opportunity within the Point of Care Infectious Disease Testing Market lies in the integration of POCT devices with digital health platforms. Integrating POCT devices with digital health platforms allows for seamless data capture, transmission, and analysis, enhancing connectivity between point-of-care testing devices, healthcare providers, and public health authorities. This integration enables real-time monitoring of infectious disease outbreaks, facilitates surveillance efforts, and supports evidence-based decision-making for disease control and prevention initiatives. Additionally, integration with digital health platforms can enhance patient engagement, enable remote monitoring, and support continuity of care beyond traditional healthcare settings.

Point of Care Infectious Disease Testing Market Market Segmentation

By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Point of Care Infectious Disease Testing Market Companies

Alere
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Labs Inc
Cardinal Health
Chembio Diagnostics Inc
F. Hoffmann-La Roche Ltd
Gene POC
OJ-Bio Ltd
Ortho-Clinical Diagnostics
Quest Diagnostics Inc
Siemens Healthineers
Sight Diagnostics Ltd
Thermo Fisher Scientific Inc
Trinity Biotech
Trivitron Healthcare

Reasons to Buy the Point of Care Infectious Disease Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Point of Care Infectious Disease Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Point of Care Infectious Disease Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Point of Care Infectious Disease Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Point of Care Infectious Disease Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Point of Care Infectious Disease Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Point of Care Infectious Disease Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Point of Care Infectious Disease Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Point of Care Infectious Disease Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Point of Care Infectious Disease Testing Industry
4.2 Key Market Trends in Point of Care Infectious Disease Testing Industry
4.3 Potential Opportunities in Point of Care Infectious Disease Testing Industry
4.4 Key Challenges in Point of Care Infectious Disease Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Point of Care Infectious Disease Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Point of Care Infectious Disease Testing Market Outlook by Segments
7.1 Point of Care Infectious Disease Testing Market Outlook by Segments, $ Million, 2021- 2030
By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

8 North America Point of Care Infectious Disease Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Point of Care Infectious Disease Testing Markets in 2024
8.2 North America Point of Care Infectious Disease Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Point of Care Infectious Disease Testing Market size Outlook by Segments, 2021-2030
By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

9 Europe Point of Care Infectious Disease Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Point of Care Infectious Disease Testing Markets in 2024
9.2 Europe Point of Care Infectious Disease Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Point of Care Infectious Disease Testing Market Size Outlook by Segments, 2021-2030
By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

10 Asia Pacific Point of Care Infectious Disease Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Point of Care Infectious Disease Testing Markets in 2024
10.2 Asia Pacific Point of Care Infectious Disease Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Point of Care Infectious Disease Testing Market size Outlook by Segments, 2021-2030
By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

11 South America Point of Care Infectious Disease Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Point of Care Infectious Disease Testing Markets in 2024
11.2 South America Point of Care Infectious Disease Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Point of Care Infectious Disease Testing Market size Outlook by Segments, 2021-2030
By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

12 Middle East and Africa Point of Care Infectious Disease Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Point of Care Infectious Disease Testing Markets in 2024
12.2 Middle East and Africa Point of Care Infectious Disease Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Point of Care Infectious Disease Testing Market size Outlook by Segments, 2021-2030
By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Alere
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Labs Inc
Cardinal Health
Chembio Diagnostics Inc
F. Hoffmann-La Roche Ltd
Gene POC
OJ-Bio Ltd
Ortho-Clinical Diagnostics
Quest Diagnostics Inc
Siemens Healthineers
Sight Diagnostics Ltd
Thermo Fisher Scientific Inc
Trinity Biotech
Trivitron Healthcare
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others